Inequities Associated With Advanced Stage at Presentation of Head and Neck Cancer

被引:2
|
作者
Ioerger, Patrick [1 ]
Mills, Kale [2 ]
Wagoner, Sarah F. [3 ]
Lawrence, Amelia [3 ]
Alapati, Rahul [3 ]
Nallani, Rohit [3 ]
Hamill, Chelsea S. [3 ]
Boakye, Eric Adjei [4 ,5 ]
Sykes, Kevin J. [1 ,6 ]
机构
[1] Univ Kansas, Sch Med, Kansas City, MO USA
[2] Univ Kansas, Sch Med Wichita, Wichita, KS USA
[3] Univ Kansas Med Ctr, 3901 Rainbow Blvd,Mailstop 3010, Kansas City, KS 66160 USA
[4] Henry Ford Hlth, Dept Publ Hlth Sci, Detroit, MI USA
[5] Henry Ford Hlth, Dept Otolaryngol Head & Neck Surg, Detroit, MI USA
[6] Baylor Scott & White Hlth & Wellness Ctr, Dallas, TX USA
关键词
SQUAMOUS-CELL CARCINOMA; LARYNGEAL-CANCER; RACIAL DISPARITIES; SURVIVAL OUTCOMES; DIAGNOSIS; IMPACT; DETERMINANTS; METASTASIS; DELAYS; RISK;
D O I
10.1001/jamaoto.2024.1180
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Importance Social determinants of health (SDoH) are defined by a wide range of factors (eg, built environment, economic stability, education level, discrimination, racism, access to health care). Advanced stage at presentation or delayed diagnosis heavily influences health outcomes in patients with head and neck cancer (HNC). While the drivers of advanced-stage presentation come from a multitude of sources, SDoH plays an outsized role. Objective To systematically review the published literature to identify which SDoH are established as risk factors for delayed diagnosis or advanced stage at presentation among patients with HNC. Evidence Review In this systematic review, a literature search of PubMed, Web of Science, and Embase was conducted on February 27, 2023, using keywords related to advanced stage at presentation and delayed diagnosis of HNC between 2013 and 2023. Quality assessment was evaluated through the Newcastle-Ottawa Scale. Articles were included if they focused on US-based populations and factors associated with advanced stage at presentation or delayed diagnosis of HNC. Findings Overall, 50 articles were included for full-text extraction, of which 30 (60%) were database studies. Race was the most commonly reported variable (46 studies [92%]), with Black race (43 studies [93%]) being the most studied racial group showing an increased risk of delay in diagnosis of HNC. Other commonly studied variables that were associated with advanced stage at presentation included sex and gender (41 studies [82%]), insurance status (25 studies [50%]), geographic region (5 studies [10%]), and socioeconomic status (20 studies [40%]). Male sex, lack of insurance, rurality, and low socioeconomic status were all identified as risk factors for advanced stage at presentation. Conclusions and Relevance This systematic review provides a comprehensive list of factors that were associated with advanced HNC stage at presentation. Future studies should focus on evaluating interventions aimed at addressing the SDoH in communities experiencing disparities to provide a net positive effect on HNC care.
引用
收藏
页码:727 / 740
页数:14
相关论文
共 50 条
  • [1] Insurance status, stage of presentation, and survival among female patients with head and neck cancer
    Panth, Neelima
    Simpson, Matthew C.
    Sethi, Rosh K. V.
    Varvares, Mark A.
    Osazuwa-Peters, Nosayaba
    LARYNGOSCOPE, 2020, 130 (02) : 385 - 391
  • [2] Travel distance is associated with stage at presentation and laryngectomy rates among patients with laryngeal cancer
    Morse, Elliot
    Lohia, Shivangi
    Dooley, Laura M.
    Gupta, Piyush
    Roman, Benjamin R.
    JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (08) : 1272 - 1283
  • [3] Guideline - Adherence in advanced stage head and neck cancer is associated with improved survival - A National study
    Cohen, Oded
    Brauer, Philip R.
    Judson, Benjamin L.
    Burtness, Barbara A.
    Earles, Joseph
    Mehra, Saral
    ORAL ONCOLOGY, 2022, 125
  • [4] Travel distance: Impact on stage of presentation and treatment choices in head and neck cancer
    Ringstrom, Mark J.
    Christian, Jay
    Bush, Matthew L.
    Levy, Jeffrey E.
    Huang, Bin
    Gal, T. J.
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2018, 39 (05) : 575 - 581
  • [5] Change in stage of presentation of head and neck cancer in the United States before and after the affordable care act
    Panth, Neelima
    Barnes, Justin M.
    Simpson, Matthew C.
    Boakye, Eric Adjei
    Sethi, Rosh K. V.
    Varvares, Mark A.
    Osazuwa-Peters, Nosayaba
    CANCER EPIDEMIOLOGY, 2020, 67
  • [6] Patterns of Discordance Between Clinical and Pathologic Stage in Head and Neck Cancer
    Hondorp, Brian
    Punjabi, Nihal
    Macias, David
    Liu, Yuan
    Frank, Ethan
    Kim, Paul D.
    Inman, Jared C.
    LARYNGOSCOPE, 2024, 134 (10) : 4284 - 4291
  • [7] Efficacy of Gefitinib and Methorexate in Patients With Advanced Stage and Recurrent Head and Neck Cancer
    Irshad, Razia
    Haider, Ghulam
    Hashmi, Madiha
    Hassan, Anusha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [8] SQUAMOUS CELL CANCER OF THE HEAD AND NECK WITH DISTANT METASTASIS AT PRESENTATION
    Kuperman, David I.
    Auethavekiat, Vorachart
    Adkins, Douglas R.
    Nussenbaum, Brian
    Collins, Sharon
    Boonchalermvichian, Chaiyaporn
    Trinkaus, Kathryn
    Chen, Ling
    Morgensztern, Daniel
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (05): : 714 - 718
  • [9] HPV-Associated Head and Neck Cancer
    Vokes, Everett E.
    Agrawal, Nishant
    Seiwert, Tanguy Y.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (12):
  • [10] Predictors of stage at presentation and outcomes of head and neck cancers in a university hospital setting
    Osazuwa-Peters, Nosayaba
    Christopher, Kara M.
    Hussaini, Adnan S.
    Behera, Anit
    Walker, Ronald J.
    Varvares, Mark A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E1826 - E1832